Pet industry merchant bank creates Baie Run Pet Products Inc. to provide high quality omega oils for dogs and cats

Mississauga, Ontario – October 23, 2017. Dane Creek Capital Corp. (‘DCCC’ or the ‘Company’), the pet industry merchant bank, today announced it has closed its acquisition of the non-manufacturing pet assets of Nature’s Way Canada (‘Nature’s Way’) and created Nova Scotia-based Baie Run Pet Products Inc. (‘Baie Run’), a wholly owned operating subsidiary to manage the business. As a result, Baie Run is now the provider of the industry-leading CanineOmega3TM and FelineOmega3TM pet supplements to be sold online and in retail stores in the United States and Canada.

Under the terms of the agreement, Nature’s Way will continue to manufacture the supplements in their current formulations and to the same high standards they are known for in the human health supplements industry. The agreement also provides for the development and manufacture of new product formulations. The purchase was completed via DCCC’s wholly owned Nova Scotia-based holding company Dockside Investco.

“We are very excited to bring Baie Run to life and with it, our newly acquired line of top quality omega-3 oils to the growing number of pet owners looking to improve the health and vitality of their pets through nutritional supplements,” said Alexandra McCann, CEO of Baie Run.

The acquisition marks the Company’s third investment in the Province of Nova Scotia with more expected to follow. The transaction was completed on October 12, 2017.

 

Leave a comment

Your email address will not be published. Required fields are marked *

The Pethealth Story

DCCC Chairman & CEO Mark Warren is the founder and former President & CEO of Pethealth Inc. which he formed in 1998. Under his leadership, Pethealth became the leading aggregator of new pet and pet owner data, the largest provider of cloud-based software to the companion animal industry, one of the largest providers of pet insurance in the US, UK & Canada and the world’s largest provider of companion animal microchip technology.

Pethealth was acquired by Fairfax Financial Holdings Limited (‘Fairfax’) in November, 2014 for all cash consideration of C$100M representing 2.1x twelve months trailing revenue, 19.6x twelve months trailing EBITDA and a 69% premium to the common share price.

So Why us?

We are entrepreneurs ourselves. We understand the challenges you face and have hands on experience turning good ideas into profitable ventures.

We know the pet industry and we’ll lend our strategic insights to the advancement of your business, whether you’re looking to sell or seeking investment.
Our review process is fast. We personally select each investment and work with our small board of directors and investment committee groups to make quick decisions.
Once approved, you’ll have sale proceeds or investment funds in hand in 60-90 days. 
We provide back office management support so you can focus on what matters most, whether that’s moving onto your next venture or growing your business in partnership with us.

Get in Touch

Phone: +1 (905) 291-0103
Fax: +1 (905) 296-1165

Mark Warren

COFOUNDER,
CHAIRMAN & CEO

Glen Tennison

COFOUNDER,
PRESIDENT & CFO